Health Economics & Outcomes Research

A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.

A retrospective claims data analysis published in JMCP found that patients with metastatic melanoma treated with PD-1 had substantially lower costs than patients treated with other first line agents.

Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.

A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.

A cost impact analysis of Medicare patients with Alzheimer's disease and dementia in their final years of life found that families and Medicaid bear the bear most of the cost burden. The authors of this JMCP article propose the need to better integrate Medicare and Medicaid to fund and improve patient outcomes.

Patients with treatment resistant depression use more resources and have significantly higher health care costs, according to a retrospective cohort published in JMCP.

HIV positive patients on single tablet regimens have better adherence and lower inpatient health costs, according to a retrospective claims data analysis published in JMCP.

HIV positive patients on single tablet regimens have better adherence and lower inpatient health costs, according to a retrospective claims data analysis published in JMCP.